Novo Integrated Sciences, Inc. (NVOS)
| Market Cap | 49.54M |
| Revenue (ttm) | 8.46M |
| Net Income (ttm) | -6.75M |
| Shares Out | 26.49M |
| EPS (ttm) | -0.28 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,808 |
| Open | 1.91 |
| Previous Close | 1.87 |
| Day's Range | 1.85 - 1.91 |
| 52-Week Range | 1.58 - 14.98 |
| Beta | -0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Oct 18, 2021 |
About NVOS
Novo Integrated Sciences, Inc., together with its subsidiaries, provides primary healthcare services. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic healt...
Financial Performance
In 2020, NVOS's revenue was $7.86 million, a decrease of -16.57% compared to the previous year's $9.42 million. Losses were -$4.92 million, 1,153.9% more than in 2019.
Financial StatementsNews
Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #NovoConnect--Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
Novo Integrated Sciences' Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutritio...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #biotech--Co-Founded by Mark Wahlberg and industry executive, Tom Dowd, PI Nutrition completes a licensing agreement with Aceniza, Inc. (an NVOS subsidiary).
Novo Integrated Sciences Launches New Patient Portal App Giving Patients More Control Over Their Healthcare
The ‘new' reality of the COVID-19 pandemic, ongoing advancements in medical technology, inter-connectivity, and blockchain technology, are all key drivers in the global healthcare system making critical...
Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Appoints Dr. Indrajit (Indra) Sinha Ph.D. as Chief Science Officer
Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences and Novo Healthnet Limited Complete Acquisition of Acenzia
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire Acenzia Inc.
Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC
Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Enters into Share Exchange Agreement to Acquire PRO-DIP, LLC
Novo Integrated Sciences Announces Formation of Medical Advisory Board
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Formation of Medical Advisory Board
Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Closing of $8 Million Registered Direct Offering
Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering
Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Preliminary Revenue and Financial Results of Second Quarter Fiscal Year ‘21
Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conferenc...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference, March 17-19, 2021
Novo Integrated Sciences Announces New Executive Hires for Novo Healthnet Limited
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences (NASDAQ:NVOS) Announces New Executive Hires for Novo Healthnet Limited
NVOS Stock Alert: 5 Things to Know About Novo Integrated Sciences as It Blasts Higher
Novo Integrated Sciences (NVOS) stock is taking off on Wednesday following an uplist to the Nasdaq Exchange and heavy trading of its shares. The post NVOS Stock Alert: 5 Things to Know About Novo Integr...
Novo Integrated Sciences Announces Uplist to The Nasdaq Capital Market
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Approved for listing on The Nasdaq Capital Market, effective 2/23/21.
Novo Integrated Sciences Announces New President of Novo Healthnet Limited
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--James Asher appointed as new President of Novo Healthnet Limited, wholly-owned Canadian subsidiary of Novo Integrated Sciences.
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences effects, on 2/1/21, a 1:10 reverse stock split of its common stock in connection with its application for uplist to Nasdaq.
Novo Integrated Sciences Announces Three New Independent Directors Appointed to its Board of Directors and Formation ...
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS--Novo Integrated Sciences Announces Three New Independent Directors Appointed to its Board of Directors and Formation of an Audit Committee.
Novo Integrated Sciences, Inc. Engages Investor Acquisition Advisors
Bellevue, Washington, November 18, 2020 – OTC PR WIRE – Novo Integrated Sciences, Inc. (OTC US: NVOS), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (th...